Scinai Immunotherapeutics Ltd.

SCNI

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001611747

SEC filings (opens in a new tab)

No open-market purchases or sales by Scinai Immunotherapeutics Ltd. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $49.1K in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Scinai Immunotherapeutics Ltd. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of SCNI: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Q1 2024	Change
Holders	12	13	+1
Shares	462.4K	409.9K	−52.5K (−11.4%)
Value	$275.2K	$212.7K	−$62.6K (−22.7%)

New holders (2)

Institutions that held Scinai Immunotherapeutics Ltd. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to SCNI in Q1 2024
Institution	Shares	Value	% of portfolio
Citadel Advisors LLC	12,214	$6.31K	0.00%
Millennium Management LLC	10,613	$5.48K	0.00%

Sold out (1)

Institutions that held Scinai Immunotherapeutics Ltd. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of SCNI in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Wells Fargo & Company	20	$12